18 April 2017 EMA/CVMP/196555/2017 Committee for Medicinal Products for Veterinary Use

MRL summary opinion 1

Alarelin All food producing species

On 12 April 2017, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion 2 recommending the inclusion of alarelin in all food producing species in Table 1 (Allowed substances) of the Annex to Commission Regulation (EU) No 37/2010, in accordance with the following table: Pharmaco-

Marker

Animal

logically

residue

species

NOT

All food

No MRL

NOT

APPLICABLE

producing

required

APPLICABLE

MRLs

Target tissues

Other

Therapeutic

provisions

classification

NO ENTRY

Agents acting

active substance Alarelin

on the

species

reproductive system

1

Summaries of opinion are published without prejudice to the Commission Decision. Applicants may request re-examination of any CVMP opinion, provided they notify the European Medicines Agency in writing of their intention to request such re-examination within 15 days of receipt of the opinion 2

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Alarelin - Summary opinion of the CVMP on the establishment of ...

On 12 April 2017, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion2 recommending the inclusion of alarelin in all food ...

62KB Sizes 0 Downloads 266 Views

Recommend Documents

Diflubenzuron - Summary opinion of the CVMP on the establishment ...
Mar 15, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... Animal species. MRLs. Target tissues. Other provisions. Therapeutic classification. Diflubenzuron Diflubenzuron. Salmonidae.

Divergent position on a CVMP opinion on the establishment of ...
Reading summary reports and the assessment report that was prepared for the current procedure, the following can be summarised: •. We do not have accessible any relevant scientific information concerning the behaviour and fate of fluazuron in milk,

Divergent position on a CVMP opinion on the establishment of ...
The CVMP has estimated the safe level based on a mathematic calculation only (even if the conclusion is that exposure does not represent a sizable part of the ...

Solvent naphtha, light aromatic - Summary opinion of the CVMP on the ...
Oct 6, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone ... Animal species. MRLs. Target tissues. Other provisions. Therapeutic classification. Solvent naphtha, light aromati

CVMP opinion on fluazuron - European Medicines Agency - Europa EU
Oct 5, 2017 - Veterinary Use on the establishment of maximum residue limits. Procedure no: EMEA/V/MRL/003471/EXTN/0002. Name of the substance: ...

Divergent position on the establishment of MRLs for fluazuron
Going through the article 7 of this regulation, point (e) states that consideration ... establishing an MRL value without any appropriate data and waiting to see ...

Summary of changes to the 'External guidance on the implementation ...
Apr 12, 2017 - indication application submitted in the context of regulatory procedures not ... are able to identify validation non-compliance at an early stage. 2.

Implementation of CVMP guideline on environmental impact ...
18 Jan 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/contact. © Europ

opinion on privatization of slaughterhouse.pdf
trade or business establishment[s] as legitimate exercise of their corporate. and/or proprietary power[s]. I. FACTUAL BACKGROUND. The City Government of ...

Paromomycin summary opinion - European Medicines Agency
Feb 15, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... Animal species. MRLs. Target tissues. Other provisions. Therapeutic classification. Paromomycin. Paromomycin All food produc

Summary of the EMA public hearing on quinolone and ...
Jun 13, 2018 - Page 2/7. Background. On 13 June 2018, the European Medicines Agency ... Page 3/7 and active pursuits or even carry out daily tasks such as ...

Eprinomectin summary opinion - European Medicines Agency
Nov 9, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/contact. © European ...

Porcine prolactin summary opinion - European Medicines Agency
Nov 9, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/contact. © European ...

pdf-1830\a-commentary-on-the-executive-summary-of-mission ...
... the apps below to open or edit this item. pdf-1830\a-commentary-on-the-executive-summary-of-mi ... ciation-of-academic-health-centers-by-geoffrey-v.pdf.

CVMP opinion for solvent naphtha, light aromatic - European ...
Oct 5, 2017 - Pursuant to Article 3 of Regulation (EC) No 470/2009 of 6 May 2009, Zoetis Belgium SA submitted to the. European Medicines Agency on 2 ...

Procedural advice on re-examination of CVMP opinions - European ...
Nov 9, 2017 - be based only on the scientific data available when the Committee ... Article 34(1) and (2) of Regulation (EC) No 726/2004 shall apply to the ...

Establishment Heterogeneity, Exporter Dynamics, and the Effects of ...
Melitz (2003) to develop a theory of international trade that emphasizes productive ... This generates what Baldwin and Krugman (1989) call exporter hysteresis.

The Development and Establishment of a Care Map ...
1Department of Nursing, Chang Gung Memorial Hospital, and Chang Gung Institute of Technology, Taoyuan, Taiwan. 2Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang. Gung Children's Hospital and Chang Gung University, Taoyua

Biennial report of the joint CVMP/CHMP working group on the ...
2. J3RsWG — Biennial report 2016/2017. Introduction. The Joint CHMP/CVMP Expert Group on 3Rs (JEG 3Rs) had been active since October 2010 with a mandate to provide advice and recommendations to the. CVMP and CHMP on all matters relating to the use

Opinion of the HMPC on a European Union herbal monograph on ...
Send a question via our website www.ema.europa.eu/contact ... The HMPC, in accordance with Article 16h(3) of Directive 2001/83/EC, as amended, and as set ...

Opinion of the HMPC on a European Union herbal monograph on ...
An agency of the European Union. Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555. Send a question via our website www.ema.europa.eu/ ...

why-the-establishment-of-business-security-systems-is-important.pdf
why-the-establishment-of-business-security-systems-is-important.pdf. why-the-establishment-of-business-security-systems-is-important.pdf. Open. Extract.

Download the GO.5 Establishment of Sri P.V. Narsimha Rao ...
Download the GO.5 Establishment of Sri P.V. Narsimha Rao Veterinary University.PDF. Download the GO.5 Establishment of Sri P.V. Narsimha Rao Veterinary ...